uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of chronic myelogenous leukemia (CML).
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Sciences.
2005 (English)In: Ann Oncol, ISSN 0923-7534, Vol. 16 Suppl 1, i52-3 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2005. Vol. 16 Suppl 1, i52-3 p.
Keyword [en]
Antineoplastic Agents/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use, Diagnosis; Differential, Humans, Incidence, Interferon-alpha/therapeutic use, Leukemia; Myeloid; Chronic/*diagnosis/*drug therapy/pathology, Neoplasm Staging, Prognosis, Risk Assessment
Identifiers
URN: urn:nbn:se:uu:diva-24936PubMedID: 15888754OAI: oai:DiVA.org:uu-24936DiVA: diva2:52710
Available from: 2007-02-08 Created: 2007-02-08 Last updated: 2011-01-12

Open Access in DiVA

No full text

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15888754&dopt=Citation

Authority records BETA

Simonsson, B

Search in DiVA

By author/editor
Simonsson, B
By organisation
Department of Medical Sciences

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 300 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf